Management of bacterial diarrhoea includes standard fluid and electrolyte therapy, vigilance
for potential complications, and use of antibiotics for children who have moderate-severe …

Shigella species and Shiga toxin-producing Escherichia coli (STEC) are agents of bloody
diarrhea that may progress to potentially lethal complications such as diarrhea-associated …

In high-income countries, antibiotics should not routinely be given to patients with acute
diarrhea unless testing demonstrates a pathogen for which antibiotics are indicated, and …

Shiga toxin-producing Escherichia coli (STEC) strains are important zoonotic foodborne
pathogens, causing diarrhea, hemorrhagic colitis, and life-threatening hemolytic uremic …

Foodborne diseases affect an estimated 600 million people worldwide annually, with the
majority of these illnesses caused by Norovirus, Vibrio, Listeria, Campylobacter, Salmonella …

Enterohemorrhagic Escherichia coli (EHEC) are the human pathogenic subset of Shiga
toxin (Stx)-producing E. coli (STEC). EHEC are responsible for severe colon infections …

Background The role of antibiotics in the treatment of Shiga toxin-producing Escherichia coli
(STEC) infection is controversial. Objectives To evaluate the association between treatment …

Objective To assess the protective effect of the novel postbiotic HM0539 from Lactobacillus
rhamnosus GG against intestinal infection by enterohemorrhagic E. coli O157: H7. Methods …

ABSTRACT Enterohemorrhagic Escherichia coli (EHEC) O157: H7 is a major etiologic agent
that causes bloody diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS) …

Background Multiple case definitions for post-diarrheal hemolytic uremic syndrome (D+
HUS) associated with Shiga toxin-producing Escherichia coli (STEC) are used across public …